FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307943483> ?p ?o ?g. }

• W4307943483 endingPage "1466" @default.
• W4307943483 startingPage "1466" @default.
• W4307943483 abstract "Depression is frequent in Parkinson’s disease (PD) patients, but the evidence for many antidepressant agents to treat it in PD is insufficient. The aim of the present prospective open-label single-arm study (VOPARK, an open-label study of the effectiveness and safety of VOrtioxetine in PARKinson’s disease patients with depression) was to analyze the effectiveness of vortioxetine on depressive symptoms in PD patients with major depression. The primary efficacy outcome was the change from baseline (VB) at the end of the observational period (12 weeks ± 14 days; V12w) in the 17-item Hamilton Depression Rating Scale (HAM-D17) total score. At VB, all patients had a HAM-D17 total score ≥16. A total of 30 patients (age 66.23 ± 10.27; 73.3% males) were included between February 2021 (first patient, 12/FEB/21) and March 2022 (last patient, 14/MAR/22). At 12 weeks, 27 patients completed the follow-up (90%). The total HAM-D17 total score was reduced by 52.7% (from 21.5 ± 4.75 at VB to 10.44 ± 7.54 at V12w; Cohen’s effect size = −2.5; p < 0.0001) and the response and remission rates were 50% and 43.3%, respectively. Apathy (Apathy Scale; p < 0.0001), cognition (PD-Cognitive Rating Scale; p = 0.007), fatigue (Fatigue Severity Scale; p = 0.014), and quality of life (PDQ-39 (p = 0.001) and EUROHIS-QOL8 (p < 0.0001)) improved at 3 weeks as well. A total of 11 adverse events in 10 patients (33.3%) were reported, one of which was severe (vomiting related to vortioxetine with full recovery after drug withdrawal). Vortioxetine was safe and well tolerated and improved depressive symptoms and other non-motor symptoms in PD patients." @default.
• W4307943483 created "2022-11-06" @default.
• W4307943483 creator A5006282136 @default.
• W4307943483 creator A5007138149 @default.
• W4307943483 creator A5011149965 @default.
• W4307943483 creator A5022912097 @default.
• W4307943483 creator A5026721368 @default.
• W4307943483 creator A5030302034 @default.
• W4307943483 creator A5044723172 @default.
• W4307943483 creator A5048562275 @default.
• W4307943483 creator A5064862140 @default.
• W4307943483 creator A5076501998 @default.
• W4307943483 creator A5080001317 @default.
• W4307943483 creator A5085267145 @default.
• W4307943483 date "2022-10-29" @default.
• W4307943483 modified "2023-10-04" @default.
• W4307943483 title "Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study" @default.
• W4307943483 cites W1497985356 @default.
• W4307943483 cites W1940288196 @default.
• W4307943483 cites W1943680688 @default.
• W4307943483 cites W1967366594 @default.
• W4307943483 cites W1969368455 @default.
• W4307943483 cites W1983176528 @default.
• W4307943483 cites W1997230335 @default.
• W4307943483 cites W2011606125 @default.
• W4307943483 cites W2018032481 @default.
• W4307943483 cites W2026772921 @default.
• W4307943483 cites W2029732660 @default.
• W4307943483 cites W2033667157 @default.
• W4307943483 cites W2036812642 @default.
• W4307943483 cites W2042158944 @default.
• W4307943483 cites W2047012550 @default.
• W4307943483 cites W2054766240 @default.
• W4307943483 cites W2059274457 @default.
• W4307943483 cites W2061378977 @default.
• W4307943483 cites W2061669920 @default.
• W4307943483 cites W2064963539 @default.
• W4307943483 cites W2064996887 @default.
• W4307943483 cites W2075378618 @default.
• W4307943483 cites W2091674068 @default.
• W4307943483 cites W2095127925 @default.
• W4307943483 cites W2103019815 @default.
• W4307943483 cites W2113285169 @default.
• W4307943483 cites W2114613490 @default.
• W4307943483 cites W2124615973 @default.
• W4307943483 cites W2130622093 @default.
• W4307943483 cites W2140374231 @default.
• W4307943483 cites W2141284201 @default.
• W4307943483 cites W2147111512 @default.
• W4307943483 cites W2152837663 @default.
• W4307943483 cites W2153262242 @default.
• W4307943483 cites W2153644230 @default.
• W4307943483 cites W2155558741 @default.
• W4307943483 cites W2156411508 @default.
• W4307943483 cites W2212064423 @default.
• W4307943483 cites W2214091681 @default.
• W4307943483 cites W2270496518 @default.
• W4307943483 cites W2276751657 @default.
• W4307943483 cites W2303297560 @default.
• W4307943483 cites W2328119063 @default.
• W4307943483 cites W2403465849 @default.
• W4307943483 cites W2548380697 @default.
• W4307943483 cites W2768642157 @default.
• W4307943483 cites W2778627188 @default.
• W4307943483 cites W2883378577 @default.
• W4307943483 cites W2908548900 @default.
• W4307943483 cites W2937407505 @default.
• W4307943483 cites W2964163087 @default.
• W4307943483 cites W2974756269 @default.
• W4307943483 cites W2984384647 @default.
• W4307943483 cites W3007197464 @default.
• W4307943483 cites W3097443229 @default.
• W4307943483 cites W3176477180 @default.
• W4307943483 cites W34103945 @default.
• W4307943483 cites W4200373130 @default.
• W4307943483 cites W4200556160 @default.
• W4307943483 cites W4205147861 @default.
• W4307943483 cites W4210265568 @default.
• W4307943483 cites W4224326081 @default.
• W4307943483 cites W4255969552 @default.
• W4307943483 cites W4280502062 @default.
• W4307943483 doi "https://doi.org/10.3390/brainsci12111466" @default.
• W4307943483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36358393" @default.
• W4307943483 hasPublicationYear "2022" @default.
• W4307943483 type Work @default.
• W4307943483 citedByCount "1" @default.
• W4307943483 countsByYear W43079434832023 @default.
• W4307943483 crossrefType "journal-article" @default.
• W4307943483 hasAuthorship W4307943483A5006282136 @default.
• W4307943483 hasAuthorship W4307943483A5007138149 @default.
• W4307943483 hasAuthorship W4307943483A5011149965 @default.
• W4307943483 hasAuthorship W4307943483A5022912097 @default.
• W4307943483 hasAuthorship W4307943483A5026721368 @default.
• W4307943483 hasAuthorship W4307943483A5030302034 @default.
• W4307943483 hasAuthorship W4307943483A5044723172 @default.
• W4307943483 hasAuthorship W4307943483A5048562275 @default.
• W4307943483 hasAuthorship W4307943483A5064862140 @default.
• W4307943483 hasAuthorship W4307943483A5076501998 @default.

• next